ACME Laboratories Ltd

DHA:ACMELAB (Bangladesh)  
BDT 64.30 (+1.1%) Jun 19
7.34
P/B:
0.56
Market Cap:
BDT 13.61B ($ 115.76M)
Enterprise V:
BDT 34.99B ($ 297.69M)
Volume:
28.06K
Avg Vol (2M):
115.66K
Trade In:
Volume:
28.06K
Avg Vol (2M):
115.66K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ACME Laboratories Ltd ( ) from 2016 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ACME Laboratories stock (DHA:ACMELAB) PE ratio as of Jun 19 2024 is 7.34. More Details

ACME Laboratories Ltd (DHA:ACMELAB) PE Ratio (TTM) Chart

To

ACME Laboratories Ltd (DHA:ACMELAB) PE Ratio (TTM) Historical Data

Total 1252
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
ACME Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 7.3 2024-04-15 8.3
2024-06-19 7.3 2024-04-14 8.3
2024-06-13 7.3 2024-04-11 8.3
2024-06-12 7.3 2024-04-10 8.3
2024-06-11 7.2 2024-04-09 8.3
2024-06-10 7.3 2024-04-08 8.2
2024-06-09 7.4 2024-04-07 8.2
2024-06-06 7.4 2024-04-04 8.2
2024-06-05 7.5 2024-04-03 8.2
2024-06-04 7.6 2024-04-02 8.2
2024-06-03 7.5 2024-04-01 8.2
2024-06-02 7.6 2024-03-31 8.3
2024-05-30 7.6 2024-03-28 8.2
2024-05-29 7.5 2024-03-27 6.5
2024-05-28 7.6 2024-03-26 6.6
2024-05-27 7.6 2024-03-25 6.6
2024-05-26 7.6 2024-03-24 6.7
2024-05-23 7.6 2024-03-21 6.8
2024-05-22 7.7 2024-03-20 6.7
2024-05-21 7.7 2024-03-19 6.6
2024-05-20 7.7 2024-03-18 6.7
2024-05-19 7.7 2024-03-17 6.8
2024-05-16 7.9 2024-03-14 6.8
2024-05-15 7.9 2024-03-13 6.8
2024-05-14 8.0 2024-03-12 6.8
2024-05-13 8.2 2024-03-11 6.9
2024-05-12 8.3 2024-03-10 7.0
2024-05-09 8.2 2024-03-07 7.0
2024-05-08 8.2 2024-03-06 7.1
2024-05-07 8.3 2024-03-05 7.1
2024-05-06 8.4 2024-03-04 7.1
2024-05-05 8.3 2024-03-03 7.2
2024-05-02 8.1 2024-02-29 7.2
2024-05-01 8.0 2024-02-28 7.2
2024-04-30 8.0 2024-02-27 7.2
2024-04-29 7.9 2024-02-26 7.2
2024-04-28 8.0 2024-02-25 7.2
2024-04-25 7.7 2024-02-22 7.3
2024-04-24 7.8 2024-02-21 7.3
2024-04-23 7.9 2024-02-20 7.3
2024-04-22 7.9 2024-02-19 7.3
2024-04-21 8.0 2024-02-18 7.3
2024-04-18 8.0 2024-02-15 7.4
2024-04-17 8.1 2024-02-14 7.4
2024-04-16 8.1 2024-02-13 7.6

ACME Laboratories Ltd (DHA:ACMELAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.